Maverick Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.46M Buy
144,457
+37,864
+36% +$926K 0.04% 67
2025
Q4
$2.41M Buy
106,593
+75,278
+240% +$1.64M 0.03% 129
2025
Q3
$631K Buy
+31,315
New +$525K 0.01% 200
2024
Q2
Sell
-23,813
Closed -$388K 335
2024
Q1
$388K Buy
+23,813
New +$372K 0.01% 281
2022
Q1
Sell
-2,329
Closed -$66K 281
2021
Q4
$66K Sell
2,329
-12,131
-84% -$377K ﹤0.01% 283
2021
Q3
$461K Buy
+14,460
New +$485K ﹤0.01% 445
2021
Q2
Sell
-1,717,913
Closed -$50.6M 723
2021
Q1
$50.6M Buy
1,717,913
+1,707,673
+16,676% +$52.5M 0.47% 35
2020
Q4
$314K Buy
+10,240
New +$312K 0.01% 450

Other funds holding ELAN

Maverick Capital's ELAN Position: Q1 2026 in Review

Maverick Capital increased its Elanco Animal Health (ELAN) stake by 36% in Q1 2026, buying an estimated $926K and bringing the position to 144,457 shares worth $3.46M. The position accounts for 0.04% of the portfolio, ranked #67.

Maverick Capital first reported a position in ELAN in Q4 2020 and has held it in 8 quarters since. The position peaked at $50.6M in Q1 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Maverick Capital held 144,457 shares of Elanco Animal Health worth $3.46M as of Q1 2026.
  • Maverick Capital bought 37,864 Elanco Animal Health shares in Q1 2026, an estimated $926K.
  • Elanco Animal Health made up 0.04% of Maverick Capital's portfolio in Q1 2026, its #67 holding.
  • Maverick Capital first reported a position in Elanco Animal Health in Q4 2020 and has held it in 8 quarters since.
  • Maverick Capital's Elanco Animal Health position peaked at $50.6M in Q1 2021.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.